A pan-European citizens' movement

Advancing Psychedelic Care Across Europe

A Europe where psychedelic care is integrated into society, grounded in human rights, scientific evidence, and collective wellbeing; where cultural practices are recognized, and people are informed about the responsible use and therapeutic potential of psychedelics.

Discover our vision
Who We Are → The Problem → Who Is Affected → The Barriers → Consequences → Our Vision → Mission & Values → Our Pillars → Get Involved → Partners
Who We Are

Born from lived experience, united across borders.

PsychedeliCare brings together citizens from Portugal to Estonia, from Ireland to Greece — each carrying their own stories, questions, and hopes into a shared effort to bring compassion and understanding to how Europe approaches mental health.

We are therapists and researchers, artists and caregivers, lawyers and teachers, families and friends. We come from different backgrounds but share a common intention: to place dignity, evidence, and humanity at the center of care.

We are grassroots by origin and by choice. Our movement grows from lived experience — from people speaking openly about suffering and about possibility. Together, we form a European movement that is open, diverse, and held together by the conviction that healing can be approached with tenderness, responsibility, and courage.

Diverse people connected across Europe

Steering Committee

The people guiding PsychedeliCare's vision and strategy.

TG
Théo Giubilei 🇫🇷
Founder & Coordinator
BM
Bárbara Messias 🇵🇹
Community Coordinator
AE
Annarita Eva 🇮🇹
National Coordinator, Italy
MK
Michelle Kronquist 🇺🇸
National Coordinator, Sweden
RS
Raphaël Saunier 🇨🇭
Strategy & Technology
AC
Flavio Avy Candeli 🇮🇹
Creative Director
CR
Ciara Reynolds 🇮🇪
National Coordinator, Ireland
CC
Chiara Coppola 🇮🇹
Advocate, Italian Team
AA
Alexis Arragon 🇫🇷
National Coordinator, France
RC
Raphaël Comte 🇫🇷
Policy & Institutional Engagement
LS
Leonie Staas 🇩🇪
Coalition-Building Co-coordinator
Why This Matters

A profound gap between evidence and action.

Europe faces a deepening mental health crisis: rising depression, trauma, anxiety, addiction, and social fragmentation. Mental health systems remain under-resourced and reliant on decades-old treatments, failing to meet the scale or complexity of need.

A growing body of rigorous scientific research demonstrates that psychedelic-assisted therapy, when delivered in clinical settings with proper preparation and integration, shows significant promise for treating conditions including treatment-resistant depression, PTSD, addiction, and end-of-life anxiety.

Yet a profound gap exists between what the science shows and what policy allows.

Scientific Reality

  • Breakthrough therapy designations from regulators
  • Clinical trials showing sustained benefits
  • Safety profiles comparable to existing treatments
  • Growing consensus among researchers and clinicians
⇌

Policy & Public Reality

  • Outdated drug classifications ignoring current evidence
  • Regulatory frameworks blocking clinical access
  • Public perception shaped by stigma and propaganda
  • Criminalization preventing research participation
The Core Problem

A collective failure to align public understanding, political decision-making, and mental health policy with the best available scientific evidence. This condition denies millions of Europeans access to safe, equitable, regulated psychedelic-assisted therapy.

Who Is Affected

Suffering that extends beyond the individual.

When evidence-based mental health care is restricted, the consequences ripple outward — from patients and families to providers, communities, and society at large.

Treatment-Resistant Populations

Those who have exhausted conventional options face chronic suffering with no clear path forward. Their families experience secondary trauma, financial strain, and social isolation.

Broader Mental Health Burden

Millions with depression, anxiety, trauma, and burnout receive inadequate care or remain untreated entirely. Without access to diverse treatment modalities, conditions may worsen.

Healthcare Providers

Clinicians and researchers possess knowledge of promising treatments but cannot offer them. Research protocols face unnecessary bureaucratic barriers.

Marginalized Communities

Those with limited resources, linguistic barriers, or lack of scientific literacy face compounded disadvantages: reduced access, greater criminalization, exclusion from trials.

Policymakers & Regulators

Decision-makers navigate competing pressures without clear evidence synthesis. They inherit policy structures that no longer serve public health goals.

Society at Large

Entire communities suffer diminished wellbeing, reduced social cohesion, and increased healthcare costs. The economic burden of untreated mental illness affects everyone.

The Barriers

Why the gap persists.

Multiple systemic, cultural, and historical forces converge to create the current situation.

Illustration prompt: Faded archival collage of 1970s anti-drug propaganda posters layered with newspaper headlines, evoking the cultural legacy of prohibition, desaturated sepia tones, torn paper edges, ghostly and historical mood, no text overlay

Illustration prompt: Imposing neoclassical government building facade with heavy locked doors, viewed from below at a steep angle, cold grey marble, a single small figure at the base, conveying institutional rigidity and inaccessibility, muted blue-grey palette

Illustration prompt: Fragmented mosaic of scientific papers and journal covers behind frosted glass, some pages visible, others obscured, representing paywalled knowledge and information asymmetry, cool lavender and grey tones, abstract and layered

Illustration prompt: Two diverging paths — one paved and lit, the other overgrown and dark — viewed from above, symbolizing unequal access to care based on resources, delicate line drawing with subtle gradient from warm to cold tones

Historical & Cultural Barriers

Legacy of the War on Drugs

Decades of prohibitionism created punitive legal frameworks that criminalize users rather than promote health. These policies were shaped more by political ideology than medical evidence, and their consequences continue to distort public perception.

Stigma & Misinformation

Public understanding remains clouded by propaganda, sensationalized media coverage, and cultural associations that overshadow scientific evidence. Fear and misconception prevent open dialogue.

Political & Regulatory Barriers

Regulatory Inertia

Drug approval and reclassification processes move slowly, even when evidence is compelling. Existing frameworks weren't designed for substances that require therapeutic context.

Political Risk Aversion

Politicians face perceived risks in supporting policy change. Lack of cross-party consensus and fear of appearing "soft on drugs" maintains the status quo despite shifting scientific consensus.

Institutional Resistance

Established systems, professional bodies, and economic interests may resist change that challenges existing treatment paradigms.

Knowledge & Capacity Gaps

Insufficient Public Education

Most Europeans lack accurate information about psychedelic research, therapeutic protocols, safety considerations, and the distinction between clinical use and recreational contexts.

Limited Clinical Infrastructure

Even where regulations permit, there are too few trained therapists, appropriate clinical settings, and institutional frameworks to deliver therapy safely at scale.

Equity & Access Barriers

Unequal Information Access

Quality information is often locked behind paywalls, published in technical language, or available only in English — creating knowledge hierarchies.

Economic Gatekeeping

Where therapy exists, access often depends on financial resources, social networks, or ability to navigate complex systems — systematically excluding those who might benefit most.

Consequences of Inaction

What happens if nothing changes.

Health

  • Continued suffering for patients who could benefit from psychedelic-assisted therapy
  • Increased rates of suicide, chronic illness, and treatment failure
  • Unsafe use without proper support, education, or harm reduction

Social & Economic

  • Massive societal costs: healthcare strain, lost productivity, pharmaceutical dependency
  • Families destabilized by unaddressed mental health burdens
  • Social fragmentation and decreased community resilience

Systemic

  • Psychiatry limited to symptom management rather than root causes
  • Innovation stalls while the crisis deepens
  • The evidence-policy gap erodes public trust in institutions and expertise
Our Vision
A resilient and healthy Europe where the personal use of psychedelics is decriminalised, where safe and equitable psychedelic-assisted therapy is accessible to those who need it, and where individuals and communities can thrive more connected and meaningful lives.
Our Mission

Creating the conditions for healing.

We create the conditions for people to explore and access psychedelic care safely, ethically, and with dignity. We ensure that Europe's evolving psychedelic landscape is guided by evidence, clear standards, and inclusive participation.

We strengthen citizen involvement by creating spaces for people to be informed, represented, and engaged. We shift public conversation from stigma toward understanding, and from narrow medical narratives toward recognition of the diverse ways people approach healing and inner experience.

Seed sprouting into growth, representing healing

Our Values

Dignity

Respect for lived experience

Integrity

Scientific transparency

Inclusion

Diverse perspectives and traditions

Responsibility

Ethical sustainability and safety

Community

Collaboration and mutual support

Our Belief

Europe can cultivate a culture of care — one where compassion and evidence reinforce one another, and where healing is approached with humility, tenderness, and responsibility.

What We Do

Three Pillars of Action

01
Community

Connecting & Strengthening the Movement

Mental health struggles thrive in isolation. Across Europe, people seeking healing, practitioners offering support, researchers building evidence, and advocates working for change often operate separately. The Community pillar creates the spaces, tools, and connections that allow Europe's diverse psychedelic community to find each other, learn together, and build collective power.

Connect Stakeholders

A comprehensive, multilingual directory linking patients, therapists, researchers, artists, families, advocates, and policymakers across borders.

Spaces for Learning

Community training in peer support, integration practices, and harm reduction. Storytelling platforms and participatory events elevating lived experience.

Direct Support

A hotline and email support for people navigating psychedelic care questions. Crisis prevention resources and safe-use education.

Collective Voice

Documenting unmet mental health needs through community testimony. Demonstrating public support for reform.

02
Education

Building Understanding & Breaking Stigma

Public understanding of psychedelics remains shaped by decades of misinformation, propaganda, and "war on drugs" narratives. The Education pillar transforms public discourse from fear to understanding, equipping diverse audiences with accurate, accessible, evidence-based information. Changing minds requires more than facts: it requires stories, trusted messengers, and meaningful engagement.

Public Awareness

Accessible educational content — books, podcasts, newsletters, social media — sharing evidence-based information through stories that humanize healing.

Professional Education

Masterclasses on therapeutic protocols. University curriculum partnerships for psychology, psychiatry, nursing, and medical programs.

Media Engagement

Supplying journalists and content creators with accurate information, expert sources, and compelling stories. Monitoring misinformation.

Reaching Decision-Makers

Educating politicians on scientific evidence and policy models. Accessible briefings translating research into policy-relevant insights.

03
Policy

Aligning Law with Evidence

The evidence-policy gap persists not because research is lacking, but because psychedelics remain criminalized under decades-old frameworks, mental health is not treated as a political priority, and fear of being seen as "soft on drugs" prevents cross-party dialogue. The Policy pillar closes this gap by equipping decision-makers, building political will, and creating regulatory pathways for safe access.

Equip Decision-Makers

Policy briefs translating scientific research into legislative insights. Sharing implementation experiences from other jurisdictions.

Build Evidence for Policy

Collecting survey data on public support. Compiling patient testimonials. Producing policy papers analyzing regulatory options.

Political Champions

Outreach across party lines. Supporting politicians willing to lead on reform. Building relationships with hospitals, universities, and advocacy groups.

Strategic Opportunities

Monitoring key policy moments. Supporting drafting of legislation. Amplifying momentum from scientific breakthroughs and international shifts.

The Change We're Creating

From what is — to what can be.

Isolation
Connection

People discover they're not alone. Patients find hope and peer support. Advocates build collective momentum across borders.

Ignorance
Understanding

Accurate information replaces myths, fear, and propaganda. The public, professionals, and policymakers gain access to evidence.

Stigma
Openness

Shame and judgment transform into curiosity, compassion, and dialogue when people understand the science.

Criminalization
Care

Psychedelics reframed as therapeutic tools rather than criminal threats. Healing is no longer punished.

Ideology
Evidence

Policy discussions grounded in public health data rather than political fear or outdated narratives.

Fragmentation
Movement

Shared resources, cross-border connections, and political champions accelerate learning and systemic change.

Our Goals

The road ahead.

3–5 Years

Political & Regulatory Shifts

  • Political champions actively advocating for reform in multiple EU countries
  • Political taboos broken across party lines
  • Implementation of the European Citizens' Initiative requests
  • Increased public research funding for psychedelic science

Professional Capacity

  • Psychedelic science integrated into university curricula
  • Healthcare professional training available in multiple languages
  • Peer support networks established in every European country

Public Awareness

  • Significantly increased public confidence and openness
  • Evidence-based, nuanced mainstream media coverage
  • Public opinion shifts toward support for regulated access
5–10 Years

Long-Term Vision

  • Psychedelic-assisted therapy available and affordable in public healthcare
  • Standard medical and psychological education includes PAT
  • Knowledge flows freely across languages and borders
  • People are not criminalized for seeking healing
  • Regulatory pathways balance safety with access
Get Involved

Join the movement.

Changing Europe's approach to psychedelic care requires all of us. Here's how you can be part of it.

Sign up to the newsletter

Get updates on policy developments, scientific breakthroughs, and community events across Europe. No spam, ever.

Follow our social media

Your financial support fuels research, advocacy, and community building across Europe. Every contribution matters.

Become a Member

Join our growing network of advocates. Members receive priority access to events, research briefings, and voting rights in our assembly.

Learn more →

One-off Donation

Make a direct impact. Every donation supports our policy research, public education campaigns, and community harm reduction programmes.

Donate now →

Corporate Partnerships

Align your organisation with the future of mental health. We offer research partnerships, sponsored events, and co-branded initiatives.

Get in touch →

We're building a pan-European network of passionate individuals. Find the role that matches your skills and availability.

Community Organiser

~8 hrs/week

Coordinate local chapters, plan meetups, and connect advocates in your city or region. Build bridges between patients, researchers, and policymakers.

Policy Research Analyst

~6 hrs/week

Track legislative developments across EU member states, draft policy briefs, and support our evidence-based advocacy with rigorous analysis.

Digital Content Creator

~5 hrs/week

Produce engaging social media content, infographics, and short videos that make complex science and policy accessible to the public.

Event Coordinator

~6 hrs/week

Plan and execute webinars, conferences, and community events. Manage speakers, logistics, and partnerships for both online and in-person gatherings.

Translation & Localisation Lead

~4 hrs/week

Ensure our message reaches all of Europe. Translate key documents, website content, and campaign materials into your native language.

Apply to volunteer

Tell us about yourself and how you'd like to contribute. We'll get back to you within a week.

Partners

The organisations building this movement with us.

PsychedeliCare collaborates with a diverse coalition of associations, research groups, non-profits, and community initiatives across and beyond Europe. Explore the network and open any partner card to learn more.

Where healing — personal, relational, and collective — is finally possible for all who need it.